Wed 25 Nov 2009 | 7:32 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Cypress Bioscience Inc

Cypress Bioscience Inc (CYPB.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty · View CYPB on other exchanges

As of 24 Nov 2009

5.40USD

Price Change

-0.12

Percent Change

-2.17%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Gendreau, R. Michael	53	2006	Vice President - Clinical Development and Chief Medical Officer
Millon, Jean-Pierre	58	2006	Lead Director
Wheeler, Denise	39	2007	General Counsel
Walsh, Michael	49	2008	Executive Vice President, Chief Compliance Officer
McGarity, Jon	67	2004	Director
Molinoff, Perry	69	2004	Director
Petree, Daniel	53	2004	Director
Hawley, Roger	56	2007	Director
Nova, Tina	55	2007	Director
Kalali, Amir	43	2007	Director
Rao, Srinivas	40	2001	Chief Scientific Officer, Director of Science and Technology
Johnson, Sabrina	43	2008	Chief Financial Officer, Chief Operating Officer, Executive Vice President
Kranzler, Jay	51	1998	Chairman of the Board, Chief Executive Officer

Find out more about CYPB.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.